HOME
PRODUCTS
LBP Series
IHC Series
FISH Series
Digital Pathology
Histology
ABOUT US
About LBP
History
Certificates
Culture
Videos
Subsidiaries
NEWS&EVENTS
Events
Academe
SUPPORT
Cervical Cancer Solutions
Downloads
FAQs
MEET US
Featured Primary Antibody
CN
EN
NEWS&EVENTS
Events
HOME
>
NEWS&EVENTS
>
17
06
LBP Completes 1st National Supervision Spot Check by NMPA 2024 for Class III Medical Devices
LBP has successfully passed the first national supervision and spot check of 2024 for Class III medical devices, conducted by the Guangdong Provincial Medical Products Administration. The inspection covered key tumor diagnostic products, including HER2 gene detection kits and HPV genotyping test kits.
MORE
06
06
LBP secures CE-IVDR Certification for 14 Pathology Products
LBP has received CE-IVDR certification for 14 key products in its pathology diagnostics portfolio, including our flagship LBP-2364 automated liquid-based cytology processor and 13 immunohistochemistry (IHC) reagents and kits. These certifications mark a major milestone in LBP's internationalization strategy.
MORE
16
05
LBP at 2025 VBEF Healthcare Conference
LBP highlights breakthroughs in AI-Driven Cytology and Diagnostics Automation at the 2025 VBEF Conference, emphasizing industry collaboration, clinical impact, and showcasing our AI-powered digital pathology innovation Xpro90.
MORE
29
04
Guangzhou LBP Medical Testing Laboratory Passes ISO15189 Review
Guangzhou LBP's Medical Testing Laboratory successfully passed a CNAS supervision review for ISO15189 accreditation in April 2025. A team of experts confirmed that the lab’s quality management system meets international standards across pathology disciplines, operations, and risk control.
MORE
19
04
AI-Enhanced Cervical Cancer Screening Gains International Recognition
A multi-institutional study led by Peking Union Medical College and published in Nature Communications highlights the successful clinical application of an AI-assisted diagnostic model for cervical cancer screening.
MORE
01
01
NMPA Class III for Gastric Cancer HER2 Detection
MORE
10
02
LBP participated in 2023 Medlab Middle East
MORE
17
01
LBP works together with Shanghai Akerman Medical Laboratory Co., Ltd to deeply collaborate in the field of CRO pharmaceutical enterprise services and companion diagnosis
MORE
28
12
LBP (688393.SH) won “the most fast-growing listed company of Biomedicine” under the list.
MORE
LOAD MORE
ONLINE MESSAGE
Please enter your contact information and we will get back to you as soon as possible.
submit
×
